Vastagbélrák: vizsgálatok itt: Kína
614 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Beijing, Hangzhou, Wuhan, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - No phaseNot yet taking people in KínaOral B-Complex Vitamin (B6, B9 and B12) Prevents Low Anterior Resection Syndrome in Rectal Cancer Patients With Hyperhomocysteinemia
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 277
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07928180 - 2/3. fázisCsak meghívásosEvaluating the Efficacy of Chidamide in the Treatment of Initial Unresectable Metastatic Colorectal Cancer With High Expression of SULF1
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 126
- Run by
- Sir Run Run Shaw Hospital
See details and how to joinNCT07927049 - 2/3. fázisCsak meghívásosEvaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 17
- Run by
- Sir Run Run Shaw Hospital
See details and how to joinNCT07927075 - No phaseTaking peoplePre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
- Where
- Fuzhou
- People
- 100
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07920770 - 1/2. fázisTaking peopleBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Where
- Changchun, Hangzhou, Harbin, Nanjing, Shanghai, Tianjin, Zhengzhou
- Életkor
- 18 év and over
- People
- 910 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06324357 - 3. fázisTaking peoplePhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Where
- Beijing, Ch’ang-ch’un, Changsha, Chengdu, Chifeng, Foshan, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Jinan, Kunming, Luzhou, Nanchang, Nanjing, Ningbo, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Yueyang, Zhengzhou, Zhuhai
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07228832 - 3. fázisTaking peopleA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Where
- Beijing, Chengdu, Guangzhou, Hangzhou, Hong Kong, Meizhou, Nanchang, Nanjing, Nanning, Shanghai, Wuhan
- Életkor
- 18 év and over
- People
- 1020 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00 - No phaseTaking peopleA Patient-Derived 3D Bioprinted Colorectal Cancer-Stroma-Immune Triad Model Uncovers Microenvironmental Mechanisms of Chemoresistance and Immune Evasion
- Where
- Ningbo
- Életkor
- 18 év and over
- People
- 60
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07919418 - No phaseNot yet taking people in KínaRAPID for Unresectable Colorectal Liver Metastases
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 10
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07919951 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Beijing, Changsha, Hangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 3. fázisTaking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Nanchang, Nanjing, Nanning, Shanghai, Shenzhen, Taiyuan, Wanzhou, Wenzhou, Wuhan, Xiamen, Xi'an, Zhengzhou
- Életkor
- 18 év and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - 1. fázisTaking peopleA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Beijing, Tianjin
- Életkor
- 18 év and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - 1. fázisTaking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - 1. fázisNot yet taking people in KínaSND002 Cell Injection in Participants With Advanced Malignant Solid Tumors
- Where
- Guiyang, Hangzhou
- Életkor
- 18 év to 80 év
- People
- 78
- Run by
- Guizhou Sinorda Pharmaceutical Co., Ltd.
See details and how to joinNCT07903857 - 2. fázisTaking peopleCirculating Tumor DNA Methylation-Guided Adjuvant Therapy Decision-Making in Patients With Resectable Colorectal Cancer Liver Metastases After Resection
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 220
- Run by
- Fudan University
See details and how to joinNCT07917104 - No phaseNot yet taking people in KínaReal-World Study: Panitumumab N01 vs Cetuximab Plus FOLFOX in First-Line RAS Wild-Type mCRC
- Where
- Fuzhou
- Életkor
- 18 év and over
- People
- 610
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07917429 - 1/2. fázisTaking peopleA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Where
- Dalian, Guangzhou, Hangzhou, Wuhan
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05379595 · EU 2023-506517-22-00 - 3. fázisTaking peopleA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Where
- Beijing, Changchun, Changsha, Guangzhou, Hangzhou, Harbin, Huizhou, Nanchang, Shanghai, Shenyang, Shenzhen, Sichuan, Taiyuan, Tianjin, Wuhan
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06662786 · EU 2024-513852-13-00 - 3. fázisTaking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Beijing, Changchun, Changsha, Chengdu, Ganzhou, Guangzhou, Hangzhou, Harbin, Huizhou, Lanzhou, Nanchang, Shanghai, Shenyang, Tianjin, Wuhan
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - No phaseNot yet taking people in KínaFeasibility Study of Huangqi Yangyuan Formula for Capecitabine-Induced Adverse Reactions in Advanced Colorectal Cancer
- Where
- Shijiazhuang
- Életkor
- 18 év to 80 év
- People
- 35
- Run by
- Huanfang Fan
See details and how to joinNCT07913516 - No phaseTaking peoplePre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery
- Where
- Nanchong
- Életkor
- 18 év to 85 év
- People
- 110
- Run by
- Nanchong Central Hospital
See details and how to joinNCT07208786 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Where
- Beijing, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou, Hefei, Hohhot, Jinan, Jining, Jinzhou, Lanzhou, Meizhou, Nanchang, Nanning, Shanghai, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Xi'an
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00 - 1/2. fázisTaking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Shanghai, Wuhan
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - 2. fázisTaking peopleIvarmacitinib Combined With Camrelizumab and Fruquintinib for Patients With Metastatic Colorectal Cancer After Failure of Second-line or Later Treatment
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 33
- Run by
- Renmin Hospital of Wuhan University
See details and how to joinNCT07896096